Anktiva 400 mcg/0.4 mL solution for intravesical use Images
Generic Name: nogapendekin alfa inbakicept
This medication has been identified as Anktiva 400 mcg/0.4 mL solution for intravesical use. It is supplied by Altor BioScience, LLC.
Anktiva is used in the treatment of Bladder Cancer and belongs to the drug class miscellaneous antineoplastics. Anktiva 400 mcg/0.4 mL solution for intravesical use is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Anktiva
- Generic Name
- nogapendekin alfa inbakicept
- Strength
- 400 mcg/0.4 mL solution for intravesical use
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Altor BioScience, LLC
- National Drug Code (NDC)
- 81481-0803
See also:
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Enfortumab vedotin
Enfortumab vedotin is used for bladder cancer, urothelial carcinoma
Mitomycin
Mitomycin is used for anal cancer, bladder cancer, pancreatic cancer, stomach cancer, urothelial ...
Durvalumab
Durvalumab (Imfinzi) is an immunotherapy used to treat lung cancer (NSCLC, SCLC) and other cancers ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
More about Anktiva (nogapendekin alfa inbakicept)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.